These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 34445638)

  • 1. Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction.
    Chou C; Chin MT
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel locus for an inherited cardiomyopathy maps to chromosome 7.
    Song L; DePalma SR; Kharlap M; Zenovich AG; Cirino A; Mitchell R; McDonough B; Maron BJ; Seidman CE; Seidman JG; Ho CY
    Circulation; 2006 May; 113(18):2186-92. PubMed ID: 16651466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel αB-crystallin R123W variant drives hypertrophic cardiomyopathy by promoting maladaptive calcium-dependent signal transduction.
    Chou C; Martin GL; Perera G; Awata J; Larson A; Blanton R; Chin MT
    Front Cardiovasc Med; 2023; 10():1223244. PubMed ID: 37435054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
    Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
    Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.
    Wijnker PJM; Sequeira V; Kuster DWD; Velden JV
    Antioxid Redox Signal; 2019 Aug; 31(4):318-358. PubMed ID: 29490477
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advances in the molecular pathogenesis of hypertrophic cardiomyopathy].
    Song YR; Liu Z; Gu SL; Qian LJ; Yan QF
    Yi Chuan; 2011 Jun; 33(6):549-57. PubMed ID: 21684859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.
    Monteiro da Rocha A; Guerrero-Serna G; Helms A; Luzod C; Mironov S; Russell M; Jalife J; Day SM; Smith GD; Herron TJ
    J Mol Cell Cardiol; 2016 Oct; 99():197-206. PubMed ID: 27620334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.
    Wolf CM; Moskowitz IP; Arno S; Branco DM; Semsarian C; Bernstein SA; Peterson M; Maida M; Morley GE; Fishman G; Berul CI; Seidman CE; Seidman JG
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18123-8. PubMed ID: 16332958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity.
    de Feria AE; Kott AE; Becker JR
    Open Heart; 2021 Feb; 8(1):. PubMed ID: 33637569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.
    de Marvao A; McGurk KA; Zheng SL; Thanaj M; Bai W; Duan J; Biffi C; Mazzarotto F; Statton B; Dawes TJW; Savioli N; Halliday BP; Xu X; Buchan RJ; Baksi AJ; Quinlan M; Tokarczuk P; Tayal U; Francis C; Whiffin N; Theotokis PI; Zhang X; Jang M; Berry A; Pantazis A; Barton PJR; Rueckert D; Prasad SK; Walsh R; Ho CY; Cook SA; Ware JS; O'Regan DP
    J Am Coll Cardiol; 2021 Sep; 78(11):1097-1110. PubMed ID: 34503678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.
    Teekakirikul P; Eminaga S; Toka O; Alcalai R; Wang L; Wakimoto H; Nayor M; Konno T; Gorham JM; Wolf CM; Kim JB; Schmitt JP; Molkentin JD; Norris RA; Tager AM; Hoffman SR; Markwald RR; Seidman CE; Seidman JG
    J Clin Invest; 2010 Oct; 120(10):3520-9. PubMed ID: 20811150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
    Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR
    Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.
    Chung H; Kim Y; Cho SM; Lee HJ; Park CH; Kim JY; Lee SH; Min PK; Yoon YW; Lee BK; Kim WS; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY; Lee KA
    Mitochondrion; 2020 Jul; 53():48-56. PubMed ID: 32380161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity-Related Cardiac Defects as a Major Disease Modifier.
    Nollet EE; Westenbrink BD; de Boer RA; Kuster DWD; van der Velden J
    J Am Heart Assoc; 2020 Nov; 9(22):e018641. PubMed ID: 33174505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
    Marian AJ; Braunwald E
    Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.
    Maron BJ; Maron MS; Maron BA; Loscalzo J
    J Am Coll Cardiol; 2019 Apr; 73(15):1978-1986. PubMed ID: 31000001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Vangipurapu J; Raivo J; Kuulasmaa T; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Vanninen S; Hämäläinen L; Melin J; Kokkonen J; Nieminen MS; ; Laakso M; Kuusisto J
    ESC Heart Fail; 2019 Apr; 6(2):436-445. PubMed ID: 30775854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic Cardiomyopathy: An Overview of Genetics and Management.
    Teekakirikul P; Zhu W; Huang HC; Fung E
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31888115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.